Advertisement

MACF1 gene variant rs2296172 is associated with T2D susceptibility in Mizo population from Northeast India

  • Freda Lalrohlui
  • Varun Sharma
  • Indu Sharma
  • Hemender Singh
  • Guneet Kour
  • Surbhi Sharma
  • Yuman
  • John Zohmingthanga
  • Vanlalhruaii
  • Ekta Rai
  • Vinod Singh
  • Nachimuthu Senthil KumarEmail author
  • Swarkar SharmaEmail author
Original Article
  • 13 Downloads

Abstract

Aim

Microtubule actin cross-linking factor 1 (MACF1) has been identified as a type 2 diabetes (T2D) candidate gene, and variant rs2296172 of the gene was found associated with T2D in multiple populations. However, it has never been explored in Mizo population. The aim of the present study was to replicate the association of variant rs2296172 of MACF1 gene with T2D in Mizo population of Northeast India.

Methodology

The variation was genotyped using TaqMan allele discrimination assay in 755 individuals (425 cases and 330 healthy controls), belonging to the Mizo population.

Results

The variant rs2296172 MACF1 was found to be significantly associated with T2D (p value = 0.001) in Mizo population group with an observed odds ratio of 1.8 [1.3–2.8] at 95% CI after correction with age, gender and BMI.

Conclusion

This study is the first replication report from Northeast India, showing variant rs2296172 of MACF1 gene associated with T2D in Mizo population. This independent study highlights MACF1 as a candidate gene for T2D in Asian Indian populations, suggesting it is critical to evaluate the variant rs2296172 in other distinct endogamous Indian population cohorts.

Keywords

Microtubule actin cross-linking factor 1 Type 2 diabetes Mizoram 

Notes

Acknowledgments

FL acknowledges DST-Inspire Fellowship for her Junior Research Fellowship. SS acknowledges grant from DST-SERB. VAS and INS acknowledge CSIR for senior research fellowship.

Authors’ contributions

NSK and SWS primarily planned the study and provided guidance throughout the study. FL and VAS prepared the manuscript. FL collected samples and, INS, SUS, GUK, YU, HS performed experimental work and JZ and VAN primarily provided the samples. VAS and IS performed statistical analyses. ER, VIS, NSK, SWS critically evaluated and compiled the study.

Funding information

The work was supported by the grant from DST-SERB, GoI grant (SB/YS/LS-91/2015) and DBT-Advanced Level State Biotech Hub, Mizoram University (BT/04/NE/ 2009 dt. 29.08.2014).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict(s) of interest.

Ethical approval

Ethical committee of Mizoram University, Aizawl, and Institutional Ethical Review Board (IERB) of Shri Mata Vaishno Devi University approved the study. The work has been approved by ethical standards of the responsible committee on human experiments (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Statement of informed consent

Informed consent was obtained from all the individuals for being included in the study.

Supplementary material

13410_2019_788_MOESM1_ESM.doc (325 kb)
ESM 1 (DOC 325 kb)

References

  1. 1.
    Meetoo D, McGovern P, Safadi R. An epidemiological overview of diabetes across the world. Br J Nurs. 2007;16(16):1002–7.  https://doi.org/10.12968/bjon.2007.16.16.27079.CrossRefPubMedGoogle Scholar
  2. 2.
    O'Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science. 2005;307(5708):370–3.  https://doi.org/10.1126/science.1104346.CrossRefPubMedGoogle Scholar
  3. 3.
    Morris AP. Progress in defining the genetic contribution to type 2 diabetes susceptibility. Curr Opin Genet Dev. 2018;50:41–51.  https://doi.org/10.1016/j.gde.2018.02.003.CrossRefPubMedGoogle Scholar
  4. 4.
    Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013;13(6):814–23.  https://doi.org/10.1007/s11892-013-0421-9.CrossRefPubMedGoogle Scholar
  5. 5.
    Federation ID. IDF- Diabetes Atlas - 8th Edition. 2017. www.idf.org. Accessed 12 September 2019
  6. 6.
    Albrechtsen A, Grarup N, Li Y, Sparso T, Tian G, Cao H, et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia. 2013;56(2):298–310.  https://doi.org/10.1007/s00125-012-2756-1.CrossRefPubMedGoogle Scholar
  7. 7.
    Sharma V, Sethi I, Sharma I, Singh G, Mahajan A, Angural A, et al. Replication of MACF1 gene variant rs2296172 with type 2 diabetes susceptibility in the Bania population group of Punjab, India. Int J Diabetes Dev Ctries. 2017;38:387–90.  https://doi.org/10.1007/s13410-017-0598-6.CrossRefGoogle Scholar
  8. 8.
    Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96.  https://doi.org/10.1016/S2213-8587(17)30174-2.CrossRefPubMedGoogle Scholar
  9. 9.
    Lalrohlui F, Thapa S, Ghatak S, Zohmingthanga J, Senthil KN. Mitochondrial complex I and V gene polymorphisms in type II diabetes mellitus among high risk Mizo-mongoloid population, Northeast India. Genes Environ. 2016;38:5–6.  https://doi.org/10.1186/s41021-016-0034-z.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24(4):224–31.  https://doi.org/10.7171/jbt.13-2404-001.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sharma V, Sharma I, Sethi I, Mahajan A, Singh G, Angural A, et al. Replication of newly identified type 2 diabetes susceptible loci in northwest Indian population. Diabetes Res Clin Pract. 2017;126:160–3.  https://doi.org/10.1016/j.diabres.2017.02.013.CrossRefPubMedGoogle Scholar
  12. 12.
    Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Control Clin Trials. 1997;18:274.CrossRefGoogle Scholar
  13. 13.
    Consortium GT. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580–5.  https://doi.org/10.1038/ng.2653.CrossRefGoogle Scholar
  14. 14.
    ensemble A. 2018. http://asia.ensembl.org. Accessed 4 Mar 2019.
  15. 15.
    Yang H, Duckett CS, Lindsten T. iPABP, an inducible poly(a)-binding protein detected in activated human T cells. Mol Cell Biol. 1995;15(12):6770–6.CrossRefGoogle Scholar
  16. 16.
    Rehfeld A, Plass M, Krogh A, Friis-Hansen L. Alterations in polyadenylation and its implications for endocrine disease. Front Endocrinol. 2013;4:53.  https://doi.org/10.3389/fendo.2013.00053.CrossRefGoogle Scholar
  17. 17.
    Sun X, Qu T, He X, Yang X, Guo N, Mao Y, et al. Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics. BMC Pregnancy Childbirth. 2018;18(1):437.  https://doi.org/10.1186/s12884-018-2066-9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kini HK, Kong J, Liebhaber SA. Cytoplasmic poly(a) binding protein C4 serves a critical role in erythroid differentiation. Mol Cell Biol. 2014;34(7):1300–9.  https://doi.org/10.1128/MCB.01683-13.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930–4.  https://doi.org/10.1093/nar/gkr917.CrossRefPubMedGoogle Scholar
  20. 20.
    Arnold M, Raffler J, Pfeufer A, Suhre K, Kastenmuller G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics. 2015;31(8):1334–6.  https://doi.org/10.1093/bioinformatics/btu779.CrossRefPubMedGoogle Scholar
  21. 21.
    Kodama A, Karakesisoglou I, Wong E, Vaezi A, Fuchs E. ACF7: an essential integrator of microtubule dynamics. Cell. 2003;115(3):343–54.CrossRefGoogle Scholar
  22. 22.
    Wu X, Kodama A, Fuchs E. ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell. 2008;135(1):137–48.  https://doi.org/10.1016/j.cell.2008.07.045.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2020

Authors and Affiliations

  1. 1.Department of BiotechnologyMizoram UniversityAizawlIndia
  2. 2.Human Genetics Research Group, School of BiotechnologyShri Mata Vaishno Devi UniversityKatraIndia
  3. 3.Department of PathologyCivil HospitalAizawlIndia
  4. 4.Department of MedicineMIMER and Associated State Referral HospitalAizawlIndia

Personalised recommendations